Bluebird Bio, INC.
Based in MA
🤖
AI Overview
With $3.5M in lobbying spend across 29 quarterly filings, Bluebird Bio, INC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2019 to 2024.
$3.5M
Total Spend
6
Years Active
1
Firms Hired
5
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $570K |
| 2020 | $780K |
| 2021 | $760K |
| 2022 | $140K |
| 2023 | $830K |
| 2024 | $390K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Pharmacy, Health Issues
- •Alternative payment models related to novel therapies.
- •Issues related to the reimbursement of gene therapies; issues related to the Patient Affordability Value and Efficiency Act.
- •Provide guidance and strategic counsel with regard to regulations and legislation that could impact the gene therapies, drug pricing and other issues that impact the industry generally, and bluebird b
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.